Showing results (131-140 of 144) with videos related to
Sort By:
Pageof 15
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 15, 2008
Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosisA K Tai, E J O'Reilly, K A Alroy, et al.American Journal of Therapeutics|November 1, 1995
The Influence of Misoprostol on the Adverse Renal Effects and Stereospecific Pharmacokinetics of Ibuprofen in Chronic Renal InsufficiencyD. W. Rudy, A. C. Rudy, P. K. Black, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 1988
Two monoclonal rat antibodies with specificity for the beta-chain variable region V beta 6 of the murine T-cell receptorJ Payne, B T Huber, N A Cannon, et al.Anesthesia and Analgesia|July 25, 2006
Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteersDaniel P Wermeling, Kenneth A Record, Thomas H Kelly, et al.Infection and Immunity|December 24, 1998
Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuriaR A Hull, D C Rudy, W H Donovan, et al.Therapeutic Drug Monitoring|December 1, 1992
Variability in the disposition of ibuprofen enantiomers in osteoarthritis patientsA C Rudy, J D Bradley, S I Ryan, et al.Urology|September 11, 2001
Pilot trial of bacterial interference for preventing urinary tract infectionR O Darouiche, W H Donovan, M Del Terzo, et al.Clinical Drug Investigation|July 5, 2011
Pharmacokinetics of oxybutynin chloride topical gel: effects of application site, baths, sunscreen and person-to-person transferenceRoger R Dmochowski, Diane K Newman, Peter K Sand, et al.Science (New York, N.Y.)|July 31, 1998
Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritisD M Gross, T Forsthuber, M Tary-Lehmann, et al.Vaccine|August 1, 1997
In vivo absorption of aluminium-containing vaccine adjuvants using 26AlR E Flarend, S L Hem, J L White, et al.Pageof 15